Accueil   Diary - News   All news Adocia Files Patent

Adocia Files Patent

 

 

Adocia Files Patent for Technology to Enable Oral Drug Delivery of Peptides

 

 

• Adocia's technology has shown promising in vivo results with the oral administration of a GLP-1 receptor agonist for the treatment of diabetes


• First-in-Human clinical study planned for 2022 to establish proof of concept


• The potential of this technology is being assessed across different therapeutic peptides and proteins

 

 

Read the press release